InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Ward Scott R., Chief Executive Officer. Officer active across 1 companies, notably Cardiovascular Systems Inc. Cumulatively, 13 filings have been published. Total volume traded: €179k. The latest transaction was disclosed on 20 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
€41,0883,000 shares@ €13.69593.7% of flow
Common Stock
SEC:0001437749-22-013310:0·
Ideal exit: 14 Feb 2023 (T+270)
€40,4122,500 shares@ €16.1653.7% of flow
Common Stock
SEC:0001437749-22-002873:0·
Ideal exit: 4 Nov 2022 (T+270)
€40,4122,500 shares@ €16.1657.6% of flow
Common Stock
SEC:0001437749-22-002873·
Ideal exit: 4 Nov 2022 (T+270)
€138,2234,593 shares@ €30.094226.0% of flow
Common Stock
SEC:0000914190-21-000318·
€138,2234,593 shares@ €30.094212.5% of flow
Common Stock
SEC:0000914190-21-000318:0·
027,842 shares0
Common Stock
SEC:0000914190-21-000303·
027,842 shares0
Common Stock
SEC:0000914190-21-000303:0·
€324,85610,570 shares@ €30.733861.1% of flow
Common Stock
SEC:0000914190-21-000265·
€324,85610,570 shares@ €30.733829.4% of flow
Common Stock
SEC:0000914190-21-000265:0·
033,141 shares0
Common Stock
SEC:0000914190-21-000235·
033,141 shares0
Common Stock
SEC:0000914190-21-000235:0·
€28,3421,000 shares@ €28.34215.3% of flow
Common Stock
SEC:0000914190-21-000143·
Ideal exit: 4 Feb 2022 (T+270)
€28,3421,000 shares@ €28.34212.6% of flow
Common Stock
SEC:0000914190-21-000143:0·
Ideal exit: 4 Feb 2022 (T+270)
13 of 13 declarations
About Ward Scott R.
Scott R. Ward is the Chairman and CEO of Cardiovascular Systems Inc. In this role, he is responsible for the strategic and operational leadership of the company. Ward plays a key role in business development and product innovation for Cardiovascular Systems, a company specializing in medical technologies. His expertise in management and strategy is essential for supporting the company's growth.
